TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15897722

Group type: EXPERIMENTAL
Intervention: 10 mg of d-amphetamine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 12917721

Group type: EXPERIMENTAL
Intervention: Group 1 (intensive treatment)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Group 2 (less intensive treatment)
Number of subjects: 43
Study: 10622016

Group type: EXPERIMENTAL
Intervention: Care provided by general practitioners (GPs)
Number of subjects: 1878

Group type: COMPARATOR
Intervention: Usual A&E staff
Number of subjects: 1878
Study: 10150320

Group type: EXPERIMENTAL
Intervention: Single 5-mg dose of ramipril
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Long-term administration of 5 mg of ramipril daily for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2201190

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg per day for 2 days)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 7003434

Group type: EXPERIMENTAL
Intervention: Group A: Shunt removal with systemic antibiotics, external ventricular drainage or intermittent ventricular taps for decompression and antibiotic administration; intravenous and intraventricular antibiotics for a minimum of 7 days.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group B: Removal and immediate replacement of the shunt with intrashunt antibiotic therapy; intravenous antibiotics for a minimum of 3 weeks and twice daily intraventricular antibiotics for a minimum of 2 weeks.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group C: Antibiotics without removal or replacement of the shunt; intravenous antibiotics for a minimum of 3 weeks and twice daily intraventricular antibiotics for a minimum of 2 weeks.
Number of subjects: 30
Study: 30975954

Group type: EXPERIMENTAL
Intervention: 150‐mg oral pregabalin and 400 mg IV ibuprofen
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 75‐mg oral pregabalin and 400‐mg IV ibuprofen
Number of subjects: 90

Group type: COMPARATOR
Intervention: 400‐mg IV ibuprofen
Number of subjects: 90

Group type: COMPARATOR
Intervention: oral placebo and IV placebo
Number of subjects: 90

Group type: COMPARATOR
Intervention: oral placebo and 400‐mg IV ibuprofen
Number of subjects: 90
Study: 28231660

Group type: EXPERIMENTAL
Intervention: Telbivudine treatment during second and third trimesters of pregnancy
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Telbivudine treatment
Number of subjects: 321

Group type: COMPARATOR
Intervention: Control group (no telbivudine treatment)
Number of subjects: 321
Study: 26297142

Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m² followed by cisplatin 75 mg/m² (Arm A)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Docetaxel + cisplatin with esomeprazole (ESOM) 80 mg p.o. bid for 3 days (Arm B)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Docetaxel + cisplatin with esomeprazole (ESOM) 100 mg p.o. bid for 3 days (Arm C)
Number of subjects: 94

Group type: COMPARATOR
Intervention: PPI (Proton Pump Inhibitors) vs no PPI
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: PPI combination in triple negative breast cancer (TNBC)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: PPI combination effect on overall survival (OS)
Number of subjects: 94
Study: 23273588

Group type: EXPERIMENTAL
Intervention: 1,000 mL/d fluid restriction
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46
Study: 22040597

Group type: EXPERIMENTAL
Intervention: Usual chiropractic care
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sham intervention (de-tuned ultrasound and de-tuned activator treatment)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 180
Study: 19148431

Group type: COMPARATOR
Intervention: 2 g of IV cephazolin in the anesthetic induction (Group C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 g of tinidazole orally, 12 hours before the surgery (Group T)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 g of tinidazole orally 12 hours before the surgery and 2g of IV cephazolin in the anesthetic induction (Group C+T)
Number of subjects: 0
Study: 16572441

Group type: EXPERIMENTAL
Intervention: Combination therapy with etanercept (25 mg subcutaneously twice weekly) and oral MTX (up to 20 mg weekly)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg subcutaneously twice weekly)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Methotrexate (up to 20 mg weekly)
Number of subjects: 503
Study: 14599040

Group type: EXPERIMENTAL
Intervention: 80 Kcal/dL formula (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 70 Kcal/dL formula (group B)
Number of subjects: 0
Study: 11138459

Group type: EXPERIMENTAL
Intervention: Epirubicin (70 mg/m2) days 1 and 8 every 4 weeks
Number of subjects: 155

Group type: COMPARATOR
Intervention: Epirubicin (60 mg/m2) days 1 and 8 plus cisplatin (100 mg/m2) day 1 every 4 weeks
Number of subjects: 155
Study: 1567032

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 100 micrograms/10 mL
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline-control 10 mL
Number of subjects: 60
Study: 3926067

Group type: EXPERIMENTAL
Intervention: 5% acyclovir cream, applied topically five times a day for five days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 45

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 45
Study: 30057223

Group type: EXPERIMENTAL
Intervention: Supplemental radial nerve release
Number of subjects: 54

Group type: COMPARATOR
Intervention: No radial nerve release
Number of subjects: 54
Study: 30509268

Group type: EXPERIMENTAL
Intervention: Correct inhalation technique
Number of subjects: 165

Group type: COMPARATOR
Intervention: Incorrect inhalation technique
Number of subjects: 165
Study: 26252976

Group type: EXPERIMENTAL
Intervention: Manually modified contours (MOD)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Automated method (AUTO)
Number of subjects: 64
Study: 24802657

Group type: EXPERIMENTAL
Intervention: Lobeglitazone 2 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Lobeglitazone 4 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23158229

Group type: EXPERIMENTAL
Intervention: Maternal worm infections (Mansonella perstans)
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Maternal worm infections (Strongyloides stercoralis)
Number of subjects: 983

Group type: EXPERIMENTAL
Intervention: Maternal anthelminthic treatment during pregnancy
Number of subjects: 983
Study: 20926997

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of corticosteroid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 0
Study: 18514620

Group type: EXPERIMENTAL
Intervention: Oral amino acid supplements alongside ACE inhibitor therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo alongside ACE inhibitor therapy
Number of subjects: 0
Study: 15928545

Group type: EXPERIMENTAL
Intervention: Individual treatment and group exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Back advice booklet and one session of advice
Number of subjects: 0
Study: 12074417

Group type: EXPERIMENTAL
Intervention: Volatile inhalation induction and maintenance (Group 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Total intravenous anaesthesia with propofol and a minimal dose sufentanil (Group 2)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate dose midazolam-sufentanil (Group 3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 10385780

Group type: EXPERIMENTAL
Intervention: gemfibrozil (1200 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: simvastatin (20 mg/day)
Number of subjects: 10
Study: 8671815

Group type: EXPERIMENTAL
Intervention: Lithium withdrawal
Number of subjects: 13

Group type: COMPARATOR
Intervention: Non-lithium control
Number of subjects: 13
Study: 1501360

Group type: EXPERIMENTAL
Intervention: Hydrolysate-containing product
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intact milk protein product
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Hydrolysate and Intact milk protein)
Number of subjects: 20
Study: 6849733

Group type: EXPERIMENTAL
Intervention: 1% pindolol eye drops
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 0.25% pindolol eye drops
Number of subjects: 12
Study: 30762274

Group type: EXPERIMENTAL
Intervention: CT-P13 (biosimilar infliximab) in the maintenance group
Number of subjects: 380

Group type: COMPARATOR
Intervention: CT-P13 (biosimilar infliximab) in the switch group
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: CT-P13 (biosimilar infliximab)
Number of subjects: 380
Study: 28298024

Group type: EXPERIMENTAL
Intervention: Subcutaneous IL-1 receptor antagonist (IL-1Ra) 100 mg administered twice daily for up to 21 days postictus.
Number of subjects: 100
Study: 26671909

Group type: EXPERIMENTAL
Intervention: Classroom-based psychological intervention (values affirmations)
Number of subjects: 0
Study: 24517632

Group type: EXPERIMENTAL
Intervention: Low HDL-C group (<40 mg/dL)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Categorized HDL-C levels
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Multivariate analysis
Number of subjects: 120
Study: 22809906

Group type: EXPERIMENTAL
Intervention: Procalcitonin group
Number of subjects: 509

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 509
Study: 20170522

Group type: EXPERIMENTAL
Intervention: LeptiCore formula A (low dose)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: LeptiCore formula B (high dose)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 17567340

Group type: EXPERIMENTAL
Intervention: TCI propofol driven by the Schnider model in effect site control
Number of subjects: 40

Group type: COMPARATOR
Intervention: TCI propofol driven by the Marsh model in plasma control
Number of subjects: 40
Study: 15606439

Group type: EXPERIMENTAL
Intervention: Epinastine (10 mg for 14 kg to <24 kg; 20 mg for ≥24 kg)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Epinastine (20 mg)
Number of subjects: 124
Study: 11911720

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 1 year during PEPI-RCT
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) for 3 years during PEPI-RCT
Number of subjects: 495

Group type: COMPARATOR
Intervention: No Hormone Replacement Therapy (Control)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Continued Hormone Replacement Therapy (HRT) after PEPI-RCT
Number of subjects: 495
Study: 10102410

Group type: EXPERIMENTAL
Intervention: Pergolide (0.51 mg as a single daily dose 2 hours before bedtime)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8751230

Group type: EXPERIMENTAL
Intervention: Treatment I (B 5 ml, OT 500 mg, M 200 mg, q.i.d. for 14 days)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Treatment II (B 10 ml, OT 750 mg, M 400 mg, q.i.d. for 7 days)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Treatment III (B 10 ml, OT 500 mg, M 400 mg, q.i.d. for 10 days)
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Follow-up after H pylori eradication
Number of subjects: 306
Study: 1679482

Group type: EXPERIMENTAL
Intervention: Urine collection from disposable nappies
Number of subjects: 45
Study: 6951254

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (1.1 mM solution)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Copper (1.1 mM solution)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silver nitrate (1.1 mM solution)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31271198

Group type: EXPERIMENTAL
Intervention: 4-year lifestyle intervention involving diet and physical activity
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1128
Study: 29023938

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention using Beers Criteria and STOPP criteria
Number of subjects: 248
Study: 25668557

Group type: EXPERIMENTAL
Intervention: 60% wt/wt ethanol solution
Number of subjects: 1460

Group type: COMPARATOR
Intervention: 0.9% saline solution (control group)
Number of subjects: 1460
Study: 23864339

Group type: EXPERIMENTAL
Intervention: Des-acyl ghrelin (DAG) infusion (3 and 10 μg DAG/kg per h)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Des-acyl ghrelin (DAG) infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Des-acyl ghrelin (DAG) infusion during hyperinsulinemic-euglycemic clamp (HEC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 21573987

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19774810

Group type: EXPERIMENTAL
Intervention: High-energy extracorporeal shock wave therapy (ESWT) - 6000 impulses (ED+ 0.78 mJ/mm2) in 3 sessions under local anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-energy extracorporeal shock wave therapy (ESWT) - 6000 impulses (ED+ 0.33 mJ/mm2) under local anaesthesia
Number of subjects: 40
Study: 17315050

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory-dose doxycycline (Oracea) - 40 mg capsule containing 30 mg immediate-release and 10 mg delayed-release doxycycline beads, taken once daily.
Number of subjects: 13000000

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 13000000
Study: 15235901

Group type: EXPERIMENTAL
Intervention: G-CSF (filgrastim, 5 microg/kg day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: G-CSF plus oral antibiotics (amoxicillin/clavulanate plus ciprofloxacin)
Number of subjects: 48
Study: 12370860

Group type: EXPERIMENTAL
Intervention: GHRH alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: GHRH plus arginine (ARG)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: SRIH withdrawal
Number of subjects: 16

Group type: COMPARATOR
Intervention: GHRH alone (Control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: GHRH plus arginine (ARG) (Control)
Number of subjects: 16
Study: 10689662

Group type: EXPERIMENTAL
Intervention: Wave 2 average alcohol consumption
Number of subjects: 596
Study: 7649670

Group type: EXPERIMENTAL
Intervention: Atrial triggered ventricular pacing (VDD)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Rate responsive ventricular pacing (VVIR)
Number of subjects: 17
Study: 2588760

Group type: EXPERIMENTAL
Intervention: ISDN 120 mg ret.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ISDN 120 mg plus Diltiazem 120 mg ret.
Number of subjects: 40
Study: 421966

Group type: EXPERIMENTAL
Intervention: Fortagesic
Number of subjects: 2

Group type: COMPARATOR
Intervention: naproxen
Number of subjects: 2
Study: 31130288

Group type: EXPERIMENTAL
Intervention: Anastrozole, 1 mg/day
Number of subjects: 82
Study: 28595614

Group type: EXPERIMENTAL
Intervention: Central Denmark Region PEWS model
Number of subjects: 14000

Group type: COMPARATOR
Intervention: Bedside PEWS model
Number of subjects: 14000
Study: 25575764

Group type: EXPERIMENTAL
Intervention: SOL (S-1 40-60 mg bid + oral LV 25 mg bid for 1 week + oxaliplatin 85 mg/m² on day 1, every 2 weeks)
Number of subjects: 107

Group type: COMPARATOR
Intervention: mFOLFOX6
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: SOL
Number of subjects: 107
Study: 24565088

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 130/0.4, preload of 15 mL.kg(‐1)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Lactated Ringer solution, preload of 30 mL.kg(‐1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 22338037

Group type: EXPERIMENTAL
Intervention: Deficient choline intake in postmenopausal women
Number of subjects: 664

Group type: COMPARATOR
Intervention: Choline intake in children, men, or premenopausal women
Number of subjects: 664
Study: 20009604

Group type: EXPERIMENTAL
Intervention: Mandibular overdenture retained by a prefabricated bar
Number of subjects: 10

Group type: COMPARATOR
Intervention: Mandibular overdenture retained by a cast bar
Number of subjects: 10
Study: 17465506

Group type: EXPERIMENTAL
Intervention: Supplemental group (Gln and rhGH), n = 22
Number of subjects: 42
Study: 15479124

Group type: EXPERIMENTAL
Intervention: Hyperlipoproteinemia patients
Number of subjects: 134

Group type: COMPARATOR
Intervention: Normolipidemic controls
Number of subjects: 134
Study: 11479493

Group type: COMPARATOR
Intervention: Conventional ultrafiltration
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration
Number of subjects: 110
Study: 9914669

Group type: EXPERIMENTAL
Intervention: Bogus-item expectancy manipulation
Number of subjects: 0
Study: 7774317

Group type: EXPERIMENTAL
Intervention: Experimental group (behavioral medicine counseling)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Monitoring control group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual treatment control group
Number of subjects: 91
Study: 3171220

Group type: EXPERIMENTAL
Intervention: UVC radiation exposure
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: UVB radiation exposure
Number of subjects: 8
Study: 30983609

Group type: EXPERIMENTAL
Intervention: Combination of topical hydroquinone 4% and fractional CO2 laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Topical hydroquinone 4%
Number of subjects: 40
Study: 29111457

Group type: EXPERIMENTAL
Intervention: Graded inferior oblique anterior transposition (IOAT); sutured at the level of the inferior rectus and 2 mm posterior for less DVD
Number of subjects: 37

Group type: COMPARATOR
Intervention: Ungraded inferior oblique anterior transposition (IOAT); both inferior oblique muscles sutured at the inferior rectus level
Number of subjects: 37
Study: 25300285

Group type: EXPERIMENTAL
Intervention: Cardi04 yogurt (300 ml milk fermented with L. helveticus)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo yogurt (300 ml artificially acidified milk)
Number of subjects: 41
Study: 23381483

Group type: EXPERIMENTAL
Intervention: Naturalistic luggage screening task (ASD group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naturalistic luggage screening task (Control group)
Number of subjects: 0
Study: 21501083

Group type: EXPERIMENTAL
Intervention: Keratoconus group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Keratoconus group (moderate and severe)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Keratoconus group (severe)
Number of subjects: 42
Study: 18444196

Group type: EXPERIMENTAL
Intervention: Web-based interactive program
Number of subjects: 44

Group type: COMPARATOR
Intervention: Traditional written material (Control)
Number of subjects: 44
Study: 16540839

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg x kg(‐1) body mass
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study: 14511730

Group type: EXPERIMENTAL
Intervention: Hydrofluoric acid etching
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Airborne particle abrasion
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Tribochemical silica coating
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Silica coating with silanization
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Thermocycling
Number of subjects: 216
Study: 10699135

Group type: EXPERIMENTAL
Intervention: Healthy Steps Program (HS) intervention group
Number of subjects: 5565

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 5565
Study: 9170475

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (intravenous study drug)
Number of subjects: 101
Study: 8251275

Group type: EXPERIMENTAL
Intervention: Intrathecal clonidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 3532353

Group type: EXPERIMENTAL
Intervention: Various new and commercially available drugs, surgery, and/or radiation therapy
Number of subjects: 1087
Study: 29846142

Group type: EXPERIMENTAL
Intervention: IRR10 (10 s inter-repetition rest)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: IRR20 (20 s inter-repetition rest)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CR (continuous repetitions)
Number of subjects: 30
Study: 26859091

Group type: EXPERIMENTAL
Intervention: scGOS/lcFOS/pAOS
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 23723435

Group type: EXPERIMENTAL
Intervention: Rhythmic musical training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Music playing in the background (Control Group 1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No music and no training (Control Group 2)
Number of subjects: 45
Study: 22948092

Group type: EXPERIMENTAL
Intervention: Forest bathing (7-day/7-night trip to a broad-leaved evergreen forest)
Number of subjects: 24

Group type: COMPARATOR
Intervention: City area control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Forest bathing
Number of subjects: 24
Study: 20307802

Group type: EXPERIMENTAL
Intervention: Movie montage with smoking scenes
Number of subjects: 100

Group type: COMPARATOR
Intervention: Movie montage without smoking scenes
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prior exposure to smoking in movies
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Level of nicotine dependence
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Contemplation stage of change
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Precontemplation stage of change
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Impulsivity
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Watching montage with smoking scenes
Number of subjects: 100
Study: 18346292

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 16613306

Group type: EXPERIMENTAL
Intervention: Computer-aided detection (CAD)
Number of subjects: 200

Group type: COMPARATOR
Intervention: No CAD (control)
Number of subjects: 200
Study: 12925071

Group type: EXPERIMENTAL
Intervention: Neoadjuvant RCT
Number of subjects: 805

Group type: COMPARATOR
Intervention: Postoperative RCT
Number of subjects: 805
Study: 11232964

Group type: EXPERIMENTAL
Intervention: Hypothermic CPB
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normothermic CPB
Number of subjects: 20
Study: 9192927

Group type: EXPERIMENTAL
Intervention: Action Plan and booklet on self-management plus supply of prednisone and antibiotics from GP
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care from GP
Number of subjects: 56